Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy

Autor: Ishii, Kei, Morii, Nao, Yamashiro, Hiroyasu

Publikováno v: Core Evidence

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a distinct subset of breast cancer that results from overexpression of HER2 protein. Pertuzumab—a recombinant humanized monoclonal antibody that binds to the extracellular di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d61726cd4b1708198de7a547e9309282
http://europepmc.org/articles/PMC6827570

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer.

Autor: Kiba T; Division of Modern Medical Technology, Institute for Clinical Research, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan., Morii N; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan; Department of Breast Surgery, Tenri Hospital, Tenri, Nara 632-8552, Japan., Takahashi H; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan., Ozaki S; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan., Atsumi M; Clinical Trial Management Office, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan., Masumoto F; Clinical Trial Management Office, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan., Shitakubo Y; Division of Modern Medical Technology, Institute for Clinical Research, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan., Yamashiro H; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737-0023, Japan; Department of Breast Surgery, Tenri Hospital, Tenri, Nara 632-8552, Japan.

Publikováno v: Molecular and clinical oncology [Mol Clin Oncol] 2016 Jan; Vol. 4 (1), pp. 47-50. Date of Electronic Publication: 2015 Nov 05.

[A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].

Autor: Nagashima S; Dept. of Pharmacy, National Hospital Organization Kure Medical Center and Chugoku Cancer Center., Kiba T, Ogawa Y, Mura T, Kajiume S, Okada Y, Morii N, Takahashi H, Ichiba Y, Yamashiro H

Publikováno v: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2015 May; Vol. 42 (5), pp. 617-9.